NEBBIOSO, Angela
 Distribuzione geografica
Continente #
EU - Europa 10.107
NA - Nord America 5.060
AS - Asia 4.273
SA - Sud America 711
Continente sconosciuto - Info sul continente non disponibili 329
AF - Africa 63
OC - Oceania 7
Totale 20.550
Nazione #
RU - Federazione Russa 6.335
US - Stati Uniti d'America 4.962
SG - Singapore 1.453
IE - Irlanda 1.056
IT - Italia 984
CN - Cina 915
HK - Hong Kong 691
BR - Brasile 602
VN - Vietnam 491
GB - Regno Unito 396
UA - Ucraina 394
DE - Germania 339
KR - Corea 224
IN - India 123
FI - Finlandia 122
SE - Svezia 113
GR - Grecia 84
TR - Turchia 82
FR - Francia 81
BD - Bangladesh 70
JP - Giappone 55
AR - Argentina 50
CA - Canada 42
NL - Olanda 42
MX - Messico 38
PK - Pakistan 34
BE - Belgio 23
IQ - Iraq 23
ID - Indonesia 22
ZA - Sudafrica 22
AT - Austria 21
PL - Polonia 20
ES - Italia 17
EC - Ecuador 15
UZ - Uzbekistan 15
CO - Colombia 12
HU - Ungheria 11
MA - Marocco 11
VE - Venezuela 9
CL - Cile 8
PT - Portogallo 8
AE - Emirati Arabi Uniti 7
CH - Svizzera 7
MY - Malesia 7
BG - Bulgaria 6
PH - Filippine 6
RO - Romania 6
SA - Arabia Saudita 6
TH - Thailandia 6
AL - Albania 5
AZ - Azerbaigian 5
EG - Egitto 5
ET - Etiopia 5
EU - Europa 5
JM - Giamaica 5
LT - Lituania 5
LV - Lettonia 5
NO - Norvegia 5
NP - Nepal 5
SI - Slovenia 5
AU - Australia 4
CZ - Repubblica Ceca 4
DK - Danimarca 4
DZ - Algeria 4
IR - Iran 4
KE - Kenya 4
KZ - Kazakistan 4
PE - Perù 4
SK - Slovacchia (Repubblica Slovacca) 4
TN - Tunisia 4
BO - Bolivia 3
HR - Croazia 3
IL - Israele 3
OM - Oman 3
PY - Paraguay 3
TW - Taiwan 3
UY - Uruguay 3
BW - Botswana 2
CR - Costa Rica 2
GT - Guatemala 2
HN - Honduras 2
JO - Giordania 2
KG - Kirghizistan 2
KH - Cambogia 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
NZ - Nuova Zelanda 2
SY - Repubblica araba siriana 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BJ - Benin 1
BS - Bahamas 1
CD - Congo 1
GF - Guiana Francese 1
GY - Guiana 1
LB - Libano 1
LC - Santa Lucia 1
LY - Libia 1
Totale 20.216
Città #
Moscow 2.257
Dublin 1.055
Singapore 730
Hong Kong 679
Santa Clara 648
Jacksonville 604
San Jose 514
Chandler 499
Ashburn 246
Seoul 212
Beijing 203
Caserta 172
Ho Chi Minh City 147
Council Bluffs 134
Naples 134
Princeton 132
Medford 116
Hefei 113
Hanoi 112
Ann Arbor 99
Boardman 91
Roxbury 85
New York 70
Bengaluru 65
Munich 65
Wilmington 64
Dallas 63
Bremen 62
São Paulo 62
The Dalles 60
Los Angeles 54
San Mateo 52
Aversa 46
Napoli 42
Orem 37
Rome 34
Woodbridge 34
Cambridge 33
Da Nang 33
Milan 32
Rio de Janeiro 32
Dong Ket 30
Des Moines 29
Nuremberg 26
Atlanta 25
Haiphong 24
Brussels 23
Nanjing 23
Mountain View 21
Amsterdam 20
Memphis 18
Norwalk 18
Brooklyn 17
Jinan 17
Warsaw 17
Düsseldorf 16
Frankfurt am Main 16
Houston 16
Redwood City 16
Boston 15
Giugliano in Campania 15
Salvador 15
Biên Hòa 14
London 14
Tianjin 14
Turku 14
Guangzhou 13
Phoenix 13
Tashkent 13
Vienna 13
Chicago 12
Mexico City 12
Chennai 11
Ercolano 11
Ferrara 11
Lappeenranta 11
Belo Horizonte 10
Buenos Aires 10
Changsha 10
Florence 10
Hangzhou 10
Helsinki 10
Hillsboro 10
Nanchang 10
Thái Nguyên 10
Auburn Hills 9
Denver 9
Hải Dương 9
Johannesburg 9
Mumbai 9
St Petersburg 9
Baghdad 8
Brasília 8
Istanbul 8
Jakarta 8
Montreal 8
Pagani 8
Paris 8
Pomigliano d'Arco 8
Porto Alegre 8
Totale 10.731
Nome #
SIRT1 pharmacological activation rescues vascular dysfunction and prevents thrombosis in MTHFR deficiency 297
C-Myc modulation and acetylation is a key HDAC inhibitor target in cancer 223
1,4-Dihydropyridines Active on the SIRT1/AMPK Pathway Ameliorate Skin Repair and Mitochondria! Function and Exhibit Inhibition of Proliferation in Cancer Cells 210
Anticancer activities of anthocyanin extract from genotyped Solanum tuberosum L. "Vitelotte" 204
Forskolin potentiates the effects of GSKJ4 in human acute myeloid leukemia cells through Protein Kinase A pathway 200
Antiproliferative, antibacterial and antifungal activity of the lichen Xanthoria parietina and its secondary metabolite parietin 199
The clinical value of HDAC2 and the p53-dependent signalling pathway in colorectal cancer 191
1,3,4-oxadiazole-containing histone deacetylase inhibitors: anticancer activities in cancer cells. 189
CBX2 shapes chromatin accessibility promoting AML via p38 MAPK signaling pathway 181
Molecular Profiling of Human Primary Chondrosarcoma-Derived Spheres Reveals Specific and Target Genes Involved in Multidrug Resistance and Metastasis 181
Inhibition of histone demethylases LSD1 and UTX regulates ERα signaling in breast cancer 179
Analysis of chromatin-nuclear receptor interactions by laser-chromatin immunoprecipitation. 174
Feijoa sellowiana derived natural Flavone exerts anti-cancer action displaying HDAC inhibitory activities 171
Different Approaches to Unveil Biomolecule Configurations and Their Mutual Interactions 171
ATTIVITÀ ANTI-PROLIFERATIVA E DIFFERENZIANTE INDOTTA DAL FRUTTO DI PSIDIUM GUAJAVA IN CELLULE LEUCEMICHE UMANE 170
Characterization of Histone Acetyltransferase-1 in cancer cells 170
ARHGEF3 controls HDACi-induced differentiation via RhoA-dependent pathways in acute myeloid leukemias. 166
Interplay between m6 A epitranscriptome and epigenome in cancer: current knowledge and therapeutic perspectives 163
Combined HAT/EZH2 modulation leads to cancer-selective cell death 163
Comparative gene expression profiling reveals partially overlapping but distinct genomic actions of different antiestrogens in human breast cancer cells 161
Molecular analysis of the apoptotic effects of BPA in acute myeloid leukemia cells 161
APOPTOSI INDOTTA DALL' ESTRATTO TOTALE ACETONICO DEL FRUTTO DI FEIJOA SELLOWIANA (BERG) IN CELLULE LEUCEMICHE UMANE 160
Two novel SIRT1 activators, SCIC2 and SCIC2.1, enhance SIRT1-mediated effects in stress response and senescence 158
BARD1 is a target of miR-19a and miR-19b: a new selective epigenetic therapy for acute myeloid lekaemias? 157
Cytotoxic Potential of the Marine Diatom Thalassiosira rotula: Insights into Bioactivity of 24-Methylene Cholesterol 155
CBX3 as a prognostic biomarker in lung cancer 154
Comparative phytochemical characterization, genetic profile, and antiproliferative activity of polyphenol-rich extracts from pigmented tubers of different solanum tuberosum varieties 154
Antiviral Activity of Vitis vinifera Leaf Extract against SARS-CoV-2 and HSV-1 153
Context-selective death of acute myeloid leukemia cells triggered by the novel hybrid retinoid-HDAC inhibitor MC2392. 153
3-Chloro-N '-(2-hydroxybenzylidene)benzohydrazide: An LSD1-Selective Inhibitor and Iron-Chelating Agent for Anticancer Therapy 152
ATTIVITA’ ANTITUMORALE DEL FLAVONE NATURALE PURIFICATO DA FEIJOA SELLOWIANA IN CELLULE DI LEUCEMIA MIELOIDE ACUTA 151
The m6A-independent role of epitranscriptomic factors in cancer 149
Enzymatic and Biological Characterization of Novel Sirtuin Modulators against Cancer 149
Exploring the Role of CBX3 as a Potential Therapeutic Target in Lung Cancer 148
"Stockpile" of Slight Transcriptomic Changes Determines the Indirect Genotoxicity of Low-Dose BPA in Thyroid Cells 145
TNF-related apoptosis-inducing ligand: Signalling of a 'smart' molecule 144
ATTIVATORI DI SIRTUINE E LORO USI 143
Acute myeloid leukemia: Therapeutic impact of epigenetic drugs 142
BRD9 binds cell type-specific chromatin regions regulating leukemic cell survival via STAT5 inhibition 142
Cardioprotective effect of a moderate and prolonged exercise training involves sirtuin pathway. 141
HDAC2 deregulation in tumorigenesis is causally connected to repression of immune modulation and defense escape. 140
AZIONE "TUMORE-SELETTIVA" DEGLI INIBITORI DELLE ISTONE DEACETILASI IN LEUCEMIE MIELOIDI ACUTE 140
Anti-leukemia activity of chaetocin via death receptor-dependent apoptosis and dual modulation of the histone methyl-transferase SUV39H1. 140
Biological interactions of biocompatible and water-dispersed MoS2 nanosheets with bacteria and human cells 140
The role of SAHA in boron uptake: harnessing epigenetic regulation of LAT1 for optimized BNCT 139
The Role of Ozone Carried by Liposomes in the Therapy of Infectious and Skin-Regenerating Ocular Surface 139
Natural compounds in epigenetics: A current view. 138
Developing novel non-hydroxamate histone deacetylase inhibitors: The chelidamic warhead 138
Discovery of the First-in-Class GSK-3β/HDAC Dual Inhibitor as Disease-Modifying Agent to Combat Alzheimer's Disease 137
RIPK1-targeting in cancer: modulation of programmed cell death process for cancer treatment 137
Selective class II HDAC inhibitors impair myogenesis by modulating the stability and activity of HDAC-MEF2 complexes 136
Time-resolved analysis of DNA-protein interactions in living cells by UV laser pulses 136
Designing Novel Dual Transglutaminase 2 / Histone Deacetylase Inhibitors Effective in Halting Neuronal Death 136
Targeting ROS production through inhibition of NADPH oxidases 135
EPIGENETIC MODULATION OF LAT1 EXPRESSION TO ENHANCE OSTEOSARCOMA SENSITIVITY TO BORON NEUTRON CAPTURE THERAPY (BNCT) 135
Preliminary Experience of Liquid Biopsy in Lung Cancer Compared to Conventional Assessment: Light and Shadows 135
Novel cinnamyl hydroxyamides and 2-aminoanilides as histone deacetylase inhibitors: apoptotic induction and cytodifferentiation activity 134
Le basi cellulari e molecolari delle malattie per le lauree triennali e magistrali 134
Gene transactivation and transrepression in myc-driven cancers 132
SIRT1 activation promotes energy homeostasis and reprograms liver cancer metabolism 132
Bispyridinium Dienes, Histone Deacetylase Inhibitors With Selective Activities 131
Cancer epigenetics: Moving forward 129
PML-RARalpha/RXR Alters the Epigenetic Landscape in Acute Promyelocytic Leukemia 128
Molecular analysis of the effects of Piroxicam and Cisplatin on mesothelioma cells growth and viability 127
Identification of NuRSERY, a New Functional HDAC Complex Composed by HDAC5, GATA1, EKLF and pERK Present in Human Erythroid Cells. 127
Synthesis and Biological Validation of Novel Synthetic Histone/Protein Methyltransferase Inhibitors 126
2-Substituted 1,5-benzothiazepine-based HDAC inhibitors exert anticancer activities on human solid and acute myeloid leukemia cell lines 125
FEIJOA SELLOWIANA DERIVED NATURAL FLAVONE EXERTS ANTI-CANCER ACTION DISPLAYING HDAC INHIBITORY ACTIVITIES 125
The Pan-Sirtuin Inhibitor MC2494 Regulates Mitochondrial Function in a Leukemia Cell Line 125
KDM4 Involvement in Breast Cancer and Possible Therapeutic Approaches 125
The HDAC inhibitor SAHA regulates CBX2 stability via a SUMO-triggered ubiquitin-mediated pathway in leukemia 124
Adipose-tumor crosstalk in colorectal cancer: Identifying (Epi)genetic biomarkers for tumor progression and cachexia 123
Forskolin sensitizes human acute myeloid leukemia cells to H3K27me2/3 demethylases GSKJ4 inhibitor via Protein Kinase A 123
Synthesis and biological properties of novel, uracil-containing histone deacetylase inhibitors 122
Design, synthesis and preliminary evaluation of a series of histone deacetylase inhibitors carrying a benzodiazepine ring. 122
Sirtuin Inhibitor Cambinol Induces Cell Differentiation and Differently Interferes with SIRT1 and 2 at the Substrate Binding Site 120
Tumor-selective action of HDAC inhibitors involves TRAIL induction in acute myeloid leukemia cells 120
Modulators of Sirtuins 119
Unravelling the impact of the chromobox proteins in human cancers 119
Histone deacetylase inhibitors induce thyroid cancer-specific apoptosis through proteasome-dependent inhibition of TRAIL degradation 119
A New Family of Jumonji C Domain-Containing KDM Inhibitors Inspired by Natural Product Purpurogallin 119
Therapeutic Potential of Natural Compounds Acting through Epigenetic Mechanisms in Cardiovascular Diseases: Current Findings and Future Directions 118
Identification of two New Synthetic Histone Deacetylase Inhibitors that Modulate Globin Gene Expression in Erythroid Cells from Normal Donors and Thalassemic Patients 118
RIP1-HAT1-SIRT Complex Identification and Targeting in Treatment and Prevention of Cancer 118
Study of 1,4-dihydropyridine structural scaffold: discovery of novel sirtuin activators and inhibitors 117
METTL16-mediated inhibition of MXD4 promotes leukemia through activation of the MYC-MAX axis 117
Identification and characterization of PKF118-310 as a KDM4A inhibitor 116
Genetic mutations in epigenetic modifiers as therapeutic targets in acute myeloid leukemia. 116
Indole-derived Psammaplin A Analogs as Epigenetic Modulators With Multiple Inhibitory Activities. 116
Epigenetic profiling of the antitumor natural product psammaplin A and its analogues 116
SIRT1 Activation by Natural Phytochemicals: An Overview 116
Evaluation of a large library of (thiazol-2-yl)hydrazones and analogues as histone acetyltransferase inhibitors: enzyme and cellular studies. 115
Pyrrole-Based Hydroxamates and 2-Aminoanilides: Histone Deacetylase Inhibition and Cellular Activities 115
Development of 1,2,4-Oxadiazoles as Potent and Selective Inhibitors of the Human Deacetylase Sirtuin 2: Structure-Activity Relationship, X-ray Crystal Structure, and Anticancer Activity 115
N{varepsilon}-lysine acetylation determines dissociation from GAP junctions and lateralization of connexin 43 in normal and dystrophic heart 114
HDAC Inhibitors Repress BARD1 Isoform Expression in Acute Myeloid Leukemia Cells via Activation of miR-19a and/or b. 113
Epigenetic Silencing of Peroxisome Proliferator-Activated Receptor γ Is a Biomarker for Colorectal Cancer Progression and Adverse Patients' Outcome 112
Discovery of Salermide-Related Sirtuin Inhibitors: Binding Mode Studies and Antiproliferative Effects in Cancer Cells Including Cancer Stem Cells. 111
L’ AZIONE TUMORE-SELETTIVA DEGLI INIBITORI DELLE ISTONE-DEACETILASI COINVOLGE L’INDUZIONE DI TRAIL IN CELLULE DI LEUCEMIA MIELOIDE ACUTA 111
Genista sessilifolia DC. extracts induce apoptosis across a range of cancer cell lines. 111
Totale 14.290
Categoria #
all - tutte 69.901
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 69.901


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022789 0 12 15 38 279 13 16 24 38 39 59 256
2022/20232.004 161 57 52 159 204 155 1 92 993 14 50 66
2023/2024772 77 26 37 60 240 76 23 25 4 10 69 125
2024/20252.579 32 25 90 78 407 356 454 234 238 282 203 180
2025/202611.070 470 531 497 632 856 5.938 576 454 410 284 243 179
2026/2027509 131 378 0 0 0 0 0 0 0 0 0 0
Totale 20.550